Navigation Links
Amalgamated Capital Serves as Syndication Agent in the Recapitalization of 180 Medical, Inc.
Date:11/10/2009

NEW YORK, Nov. 10 /PRNewswire/ -- Amalgamated Capital, a newly formed division of Amalgamated Bank, announced today that it acted as Syndication Agent in the recapitalization of Oklahoma City-based 180 Medical, Inc., a transaction led by Madison Capital Funding LLC. Amalgamated Capital provides senior cash flow debt financing to lower middle market companies for which leading private equity firms and other investors are financial sponsors.

180 Medical is majority-owned by Cortec Group Fund IV, L.P., an affiliate of the Cortec Group, a New York-based private equity firm which invests in middle-market manufacturing, distribution, healthcare, and proprietary services businesses. A leading direct distributor of disposable, single-use (intermittent) urologic catheters to individual patients, 180 Medical's comprehensive inventory includes more than 500 types of urologic catheters used by individuals afflicted by spinal cord injuries, spina bifida, multiple sclerosis and other conditions causing incontinence.

"This is exactly the type of transaction we had in mind when we formed Amalgamated Capital," said Timothy Clifford, Executive Vice President and Head of Amalgamated Capital. "Our target market is smaller middle market companies - particularly companies backed by leading private equity firms - that have strong historical cash flow and senior cash flow debt financing needs of $5 million to $60 million. Our goal is to build a national franchise that will serve several industries including healthcare."

"Since its founding, 180 Medical has experienced exceptional growth and profitability," said Michael E. Najjar, Senior Managing Director of Cortec Group. "It benefits from strong industry fundamentals and a superior service offering. Most importantly, it has achieved outstanding customer acquisition and retention and has excellent prospects of penetrating new and existing geographic markets through an expanded sales and marketing effort."

Todd Brown, 180 Medical's President and Chief Executive Officer, added, "This infusion of debt capital will give us the means to move ahead with a far broader sales and marketing program with the assistance of Cortec, our financial sponsor. We enthusiastically chose Cortec as a partner because of its success in making medical products investments and its experience in growing businesses through sales organization development."

About Amalgamated Capital

Amalgamated Capital is the leveraged lending division of Amalgamated Bank. It is focused on providing senior cash flow debt financing to smaller middle market companies, sponsored by private equity firms. In addition to healthcare services and products, Amalgamated Capital has experience across a broad range of other industries, including business services, consumer and industrial products, education, niche manufacturing, value-added distribution, software and IT outsourcing. Its lending activity is supported by a stable and substantial retail depository base, which allows Amalgamated Capital the long-term lending capacity to provide flexible financing solutions tailored to a transaction's unique needs and the patience to be a trusted partner.

Amalgamated Capital provides a wide range of financing products including, revolving lines of credit, senior cash flow term loans and one-stop financings, stand-by letters of credit and owner-occupied commercial mortgages. The division offers a streamlined approach to financing that avoids cumbersome bureaucracy resulting in a responsive, fully integrated underwriting and approval process tailored to meet the time sensitive needs of the private equity community.

Amalgamated Bank, established in 1923 by the Amalgamated Clothing Workers of America, continues the progressive traditions of its founders as the only union-owned bank in the United States. Chartered by New York State, Amalgamated Bank is an FDIC insured commercial bank with $4.5 billion in assets. It has 21 retail branches including 15 in New York City as well as branches in: Las Vegas, Nevada; Lyndhurst, New Jersey; Pasadena, California and Washington, D.C. The Bank's website is www.amalgamatedbank.com. The Bank's corporate divisions - in addition to Amalgamated Capital - include Institutional Asset Management and Custody, Commercial Banking, and Real Estate Finance.

About 180 Medical, Inc.

Founded in 2002, 180 Medical is one of America's fastest growing "nationally accredited" providers of sterile use catheters, urologic and disposable medical supplies. 180 Medical distributes disposable, single-use urologic catheters to customers in the home setting and offers over 500 types of urologic catheters from all leading manufacturers. The Company typically serves long-term customers with chronic medical diagnoses such as spinal cord injuries, spina bifida, multiple sclerosis and other conditions causing incontinence and is networked with and covered by thousands of health plans, insurance networks, state Medicaid organizations, and Medicare. The Company acquires new customers through its relationships with an extensive and growing group of urologists that refer patients to 180 Medical because of its superior medical documentation management, product education and patient counseling. For additional information, please visit www.180medical.com.

About Cortec Group

Cortec Group is a New York-based private equity firm which acquires high value-added, middle-market manufacturing, service, healthcare and distribution businesses that have achieved leadership positions in their market niches. With the acquisition of 180 Medical in September, Cortec Group has now completed twelve health care acquisitions since 2000. Cortec Fund IV has more than $410 million of committed capital to acquire platform companies with enterprise values of $30 million to $250 million and smaller follow-on acquisitions. Additional information about Cortec can be found at www.cortecgroup.com.

    Contacts:
    Bob Rinklin, E-Public Relations
    +1-973-509-3431, +1-973-768-2425 or rinklin@comcast.net

    Laura Rzasa, Donley Communications
    +1-212-751-6126 or lrzasa@donleycomm.com

SOURCE Amalgamated Capital


'/>"/>
SOURCE Amalgamated Capital
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
2. AtriCure to Present at Roth Capital Partners 2007 New York Conference
3. Doctors and medical ethicist discuss whether doctors should participate in capital punishment
4. Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment
5. Osteotech to Present at First Albany Capitals Regenerative Technologies Conference in New York
6. iCAD to Present at Americas Growth Capital 4th Annual Emerging Growth Conference
7. Pharsight Files Application for Nasdaq Capital Market Listing
8. Advanced Life Sciences Joins NASDAQ Capital Market
9. Foundation Venture Capital Group, LLC Invests in Start Up Committed to Breast Cancer Diagnostics
10. Bally Total Fitness Emerges From Chapter 11 and Closes Transaction with Harbinger Capital Partners Funds
11. Caxton-Iseman Capital Acquires Conney Safety Products, LLC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... choose a modern procedure that achieves results in a fraction of the time ... Las Vegas, NV, with Significance Dental Specialists, now offers this revolutionary treatment with ...
(Date:4/25/2017)... ... April 25, 2017 , ... Back Pain Centers of America ... a reputable physician in their area, announces the launch of a new and proprietary ... who are looking for reputable physicians to help them with back or neck pain ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... addition of predictive analytics to its patient care management module. Using this new ... before a patient has been initiated on continuous positive airway pressure (CPAP), oral, ...
(Date:4/25/2017)... ... 2017 , ... Vetoquinol USA® , a world-class developer ... of the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in Lexington. ... level. , The scientifically-developed Flexadin UCII supports the body’s normal repair of cartilage ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... technology yesterday, featuring Bring Your Own Device (BYOD) capabilities at Telehealth 2.0, the ... CNS’ pre-packaged telehealth bundles, which pairs medical devices with a pre-programmed tablet in ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... PARIS , April 20, 2017 ... EyeCET platform, the first non-viral gene expression technology that ... in the eye to address a wide range of ... UK Medicines and Healthcare products Regulatory Agency (MHRA) to ... ...
(Date:4/19/2017)... Cardiology devices segment is anticipated to reach the highest market ... segment is likely to create absolute $ opportunity of a ... By the end of 2027, Cardiology Devices segment is projected ... expanding at a CAGR of 18.4% over the forecast period. ... reprocessed medical devices market in terms of revenue ...
(Date:4/19/2017)... NEW YORK , April 19, 2017 /PRNewswire/ ... This report on the prostate cancer ... of the global market. Increasing prevalence of prostate ... as innovation in the development of new drugs ... hormone-refractory prostate cancer drug due to lesser side ...
Breaking Medicine Technology: